CA-based AliveCor announced that it has raised $65 million in its series E financing round. Among the participants were existing investors OMRON, Khosla Ventures, WP Global Partners, Qualcomm Ventures and Bold Capital Partners.
AliveCor is pioneering FDA-cleared machine learning techniques that enable proactive heart care. The company's fresh funding will accelerate the growth of AliveCor's remote cardiology platform, both domestically and around the world.
As part of the financing, the company is also partnering with OMRON, which will position the company to include hypertension management within its service portfolio.
“We are grateful for the continued confidence of our investors,” said Priya Abani, CEO of AliveCor. “This financing speaks to the transformative power our technology brings to the healthcare system. We remain positioned to fulfill our vision of delivering AI-based, remote cardiological services for the vast majority of cases when cardiac patients are not in front of their doctor.”
AliveCor has served over a million customers worldwide, and its products have recorded more than 85 million ECGs. This gives the company an advantage in building new AI-based services to drive a new age of advanced and improved cardiological care. The company believes that its efforts will significantly affect the cost, quality, and responsiveness of AI-powered diagnostics.